ISRCTN ISRCTN65345295
DOI https://doi.org/10.1186/ISRCTN65345295
ClinicalTrials.gov (NCT) Nil known
Clinical Trials Information System (CTIS) Nil known
Protocol serial number 2-2018
Sponsor University of Kocaeli
Funder Investigator initiated and funded
Submission date
02/08/2021
Registration date
10/08/2021
Last edited
09/08/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Eye drops are commonly used in the treatment of eye conditions. They are used for the prevention or treatment of infective or inflammatory disorders, to prevent and decrease the complaints of dry eye, and for eye examinations.
Failure to properly administrate eye drops can prolong the condition, clinical outcomes can be negatively affected and may present a risk to the patients’ vision.
The aim of this study is to investigate whether instillation of cyclopentolate eye drops to the corner of the eye and immediately opening the eyelid or opening of the lids in few seconds after instillation would make any difference on dilating the pupil and feeling of irritation while also comparing the traditional method with these two methods.

Who can participate?
Patients who require eye drops for eye examination

What does the study involve?
Participants were split into two groups. In both groups, one drop was administered in the traditional method into the right eye; in the left eye, the drop was instilled while the lids were closed. In the first group, the patient was asked to open his or her eye immediately, in the second group the patient was asked to open his or her eye after 10 seconds. The diameters of both pupils were measured before and after 40 minutes after the instillation of the eye drop. After the instillation, the feeling of irritation was evaluated with a visual analogue scale (VAS).

What are the possible benefits and risks of participating?
Patients might benefit from a more comfortable eye drop instillation experience, while the risk is the need for second eye drop instillation in the case the investigated method fails.

Where is the study run from?
University of Kocaeli (Turkey)

When is the study starting and how long is it expected to run for?
November 2017 to January 2019

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dr Neriman Elibol, nerimanelibol@gmail.com

Contact information

Dr Neriman Elibol
Scientific

Kocaeli Üniversitesi Sağlık Bilimleri Fakültesi Umuttepe Yerleşkesi
Kocaeli
41000
Türkiye

ORCiD logoORCID ID 0000-0003-1204-1259
Phone +90 5425719696
Email nelibol@kocaeli.edu.tr

Study information

Primary study designInterventional
Study designSingle center interventional non-randomized controlled trial
Secondary study designNon randomised study
Study type Participant information sheet
Scientific titleComparing efficiency of different eye drop instilling methods to traditional method within 10-70 age old patients.
Study objectivesThere is no difference on efficiency between traditional and new eye drop instilling methods.
Ethics approval(s)Approved 07/02/2018, Ethical Committe of Kocaeli University (Kocaeli Üniversitesi Umuttepe Yerleşkesi İzmit/Kocaeli; +902623037500; etikkurul@kocaeli.edu.tr), ref: KÜ GOKAEK 2018/32
Health condition(s) or problem(s) studiedEye drop instillation method comparison
InterventionParticipants were randomly allocated to one of two groups. Participant patients arrive in a random time sequence (Patients arrive for periodic eye examination and asked to join the study prior to the examination and if volunteered patient consents are taken. Patients are not aware of which group they are participating in). The first patient was registered to group 1 and second to group 2 third to group 1 and so on until registrations are closed.

One drop of cyclopentolate was administered in the traditional method with the patient’s head tilted back, the lower eyelid held and drop instilled into the inferior fornix in right eye. In the left eye the drop was instilled to the inner canthus while the lids were closed.

In the first group the patient was asked to open his or her eye immediately, in the second group the patient asked to open his or her eye after 10 seconds.
Intervention typeBehavioural
Primary outcome measure(s)

Pupil size was measured under constant illumination with the Plusoptix A09 autorefractometer. The diameters of both pupils were measured before and after 40 minutes after the instillation of the eye drop. All drops were instilled by the same investigator while all pupil measurements were made by an ophthalmic specialist technician unaware of the study.

Key secondary outcome measure(s)

Feeling of irritation was evaluated with visual analogue scale (VAS), patients were asked how much irritation felt according to the scale 40 minutes after eye drop instillation

Completion date30/01/2019

Eligibility

Participant type(s)Patient
Age groupMixed
SexAll
Target sample size at registration60
Total final enrolment94
Key inclusion criteria1. In need of pupil dilatation for ophthalmic examination.
2. Volunteering to participate in this study
Key exclusion criteria1. Patient requests to be excluded
2. Patients who use of ocular and systemic medications known to affect pupil size,
3. Patients who have pupil effecting disorders like pseudoexfoliation syndrome and pupillary membranes,
4. Patients with history of ocular surgery and trauma and cyclopentolate allergy
Date of first enrolment01/02/2018
Date of final enrolment01/11/2018

Locations

Countries of recruitment

  • Türkiye

Study participating centre

Dünyagöz İzmit Hastanesi
Kadıköy
Atatürk Blv. No:2
Kocaeli
41050
Türkiye

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryStored in repository
IPD sharing planThe datasets generated during and/or analysed during the current study will be stored in a publically available repository

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Dataset 26/07/2021 03/08/2021 No No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

09/08/2021: Trial's existence confirmed by Kocaeli University